NFE2L2 and colon carcinoma: Li et al. [46] demonstrated that the Nrf2-Keap1 signaling pathway mediates protective cellular responses to mitigate nitric oxide-induced damage and may contribute to the relative resistance of human colon carcinoma cells to nitric oxide-induced cytotoxicity.